CORT
CORT
NASDAQ · Pharmaceuticals

Corcept Therapeutics Inc

$110.29
-4.57 (-3.98%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 1 8%
Sell 1 8%
Price Target
Analyst Price Target -7.2% upside
Low Target $62.31
Average Target $102.33
High Target $121.34
Current Price $110.29
Current
$110.29
Target
$102.33
$62.31 $102.33 avg $121.34
Scenario Analysis
Bear Case
$62.31
-43.5%
Low target
Base Case
$102.33
-7.2%
Avg target
Bull Case
$121.34
+10.0%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$126.38
-12.7% from high
52-Week Low
$28.66
+284.8% from low
50-Day SMA
$53.13
+107.6% vs SMA
200-Day SMA
$69.00
+59.8% vs SMA
RSI (14)
26.0
Oversold
Target vs 52W High
$102.33
-19.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.0%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +10.5%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.1%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.5%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +177.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.9%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.9%